Cell reprogramming therapy for Parkinson’s disease

Cell reprogramming therapy for Parkinson’s disease

Parkinson’s disease is typically characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Many studies have been performed based on the supplementation of lost dopaminergic neurons to treat Parkinson’s disease. The initial strategy for cell replacement the...

Full description

Bibliographic Details
Main Authors: Wenjing Dong, Shuyi Liu, Shangang Li, Zhengbo Wang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-01-01
Series:Neural Regeneration Research
Subjects:
animal models; astrocytes; autologous; cell reprogramming; cell therapy; direct lineage reprogramming; dopaminergic neurons; induced pluripotent stem cells; non-human primates; parkinson’s disease
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=11;spage=2444;epage=2455;aulast=

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2024;volume=19;issue=11;spage=2444;epage=2455;aulast=

Similar Items